Long-term results from a randomized trial confirmed that early rituximab monotherapy for advanced-stage, asymptomatic, low ...

and ALBANY, N.Y., April 22, 2025 /PRNewswire/ -- OneOncology, a physician-led national platform empowering independent oncology practices, and New York Oncology and Hematology (NYOH ... collaborative ...

Researchers have identified a new set of urine-based biomarkers that can accurately detect both the presence and severity of ...

Cancer Research UK, the Bob Willis Fund, the Peacock Trust, and the National Institute for Health and Care Research to the Biomedical Research Centre at the Institute of Cancer Research and the ...

Mendus AB ("Mendus" publ; IMMU. ST), a biopharmaceutical company focused on immunotherapies targeting tumor recurrence, today announced the appointment of Tariq Mughal, MD FRCP FRCPath, as Chief Medic ...

But some UK faculty at the helm of that research worry the Trump Administration’s vast cuts in the name of efficiency and cost-savings portend debilitating impacts to this research, which is primarily ...

Landmark Science, a premier provider of real-world evidence (RWE) solutions, is redefining industry standards with its white-glove, high-touch approach to evidence generation. With long-standing roots ...

We recently published a list of Top 11 Small Cap Stocks to Buy with Biggest Upside Potential. In this article, we are going ...

In this article, we will look at the Top 11 Small Cap Stocks to Buy with Biggest Upside Potential.

Ingelheim, Germany / Ridgefield, Conn., U.S., April 28, 2025New data from the Phase Ib Beamion LUNG-1 trial were presented at AACR and simultaneously published in The New England Journal of ...

We were, in the blink of an eye, an oncology family." Rhabdomyosarcoma is a rare soft tissue cancer. “Almost all rhabdomyosarcoma are from random mutation,” says Donna Johnston, MD, FRCPC, FAAP, who ...

Q1 2025 Earnings Conference Call April 29, 2025 6:45 AM ETCompany ParticipantsAndy Barnett - Head of IRPascal Soriot ...